During the past decade, Mercy Regional Cancer Center at Mercy Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 87 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Regional Cancer Center at Mercy Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 56 trials, followed by "SWOG Cancer Research Network" with 39 trials sponsored, "Radiation Therapy Oncology Group" with 9 trials sponsored, "Eastern Cooperative Oncology Group" with 8 trials sponsored and "NSABP Foundation Inc" with 8 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Regional Cancer Center at Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 125 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Regional Cancer Center at Mercy Hospital" are "Breast Cancer" (28 trials), "Lung Cancer" (24 trials), "Prostate Cancer" (11 trials), "Lymphoma" (10 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (10 trials). Many other conditions were trialed in "Mercy Regional Cancer Center at Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Mercy Regional Cancer Center at Mercy Hospital" are "Drug" (93 trials), "Other" (40 trials), "Biological" (35 trials), "Radiation" (20 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (22 trials), "bevacizumab" (13 trials), "carboplatin" (12 trials), "cyclophosphamide" (10 trials) and "radiation therapy" (9 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Regional Cancer Center at Mercy Hospital" are 97 trials for "All" genders, 20 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Regional Cancer Center at Mercy Hospital". undefined are not yet recruiting, undefined are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 103 completed trials in Mercy Regional Cancer Center at Mercy Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Regional Cancer Center at Mercy Hospital, 4 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".